digestVidSign in
summary

UCLA Health - Is Thyroid Radiofrequency Ablation RFA Right for Me? Part One | UCLA Endocrine Center

Thumbnail of the video “UCLA Health - Is Thyroid Radiofrequency Ablation RFA Right for Me? Part One | UCLA Endocrine Center”
Community upload. AI output has not been independently verified.
Author: UCLA Health
Categories: Health
Tags: health
Views: 2 · Last viewed: 2026-10-16 15:01 UTC

Short Summary

Main recommendation: Thyroid radiofrequency ablation (RFA) is a non-surgical option for shrinking a large, symptomatic benign thyroid nodule, but only after two benign biopsies (FNAs) confirm the nodule is not cancer. The video says RFA is a poor fit for suspicious nodules, small asymptomatic nodules, or nodules without two benign biopsy results.

Key Points

  • RFA uses heat delivered through a thin needle under ultrasound guidance to shrink the nodule, with no stitches, no general anesthesia, and no hospital stay.
  • The speaker says the nodule typically shrinks by about 50 to 80%, relieving symptoms and improving appearance without removing part of the thyroid.
  • Qualifying symptoms include a visible neck lump, pressure or tightness, difficulty swallowing, discomfort lying down, or the nodule interfering with daily life.
  • Small, stable nodules under 2 cm that are not growing are usually just monitored with periodic ultrasound rather than treated.
  • RFA is not currently used to treat thyroid cancer or nodules suspicious for cancer; if there is any uncertainty, surgery is likely recommended.

Details Worth Noting

  • Concrete instructions: Confirm that you have had two separate fine needle aspiration biopsies with benign results before pursuing RFA. Check that the nodule is large and causing symptoms such as pressure, a visible lump, or swallowing difficulty. If the nodule is under 2 cm and not growing, expect periodic ultrasound monitoring instead. If you have already had thyroid surgery and want to avoid another operation, RFA is noted as an alternative.
  • Surgery remains a strong option, especially when cancer is a concern or multiple nodules are present.
  • RFA may appeal to patients who want to avoid a scar or preserve as much thyroid function as possible.
  • The speaker presents RFA as a quicker-recovery alternative, with patients going home the same day.
  • This is a summary of what the speaker says, not professional medical advice; decisions should be made with a clinician.

Bottom Line

RFA is a niche, same-day option for a benign, symptomatic thyroid nodule, and its eligibility hinges on two benign biopsies and the absence of cancer suspicion.